Interchangeability of 3 recombinant anti-HBV vaccines in primary schedule, irrespective of dose and HBsAg subtype: the first prospective, open-label, randomized study in healthy adult population
Weronika Rymer, Małgorzata Zalewska, Aleksandra Szymczak, Anna Zubkiewicz-Zarębska, Brygida Knysz